Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2025 Apr 29;56(1):110.
doi: 10.1007/s12029-025-01235-7.

Submucosal Tunneling Endoscopic Resection for Upper Gastrointestinal Subepithelial Lesions: A Systematic Review and Meta-Analysis

Affiliations
Meta-Analysis

Submucosal Tunneling Endoscopic Resection for Upper Gastrointestinal Subepithelial Lesions: A Systematic Review and Meta-Analysis

Stavros Chrysovalantis Liapis et al. J Gastrointest Cancer. .

Abstract

Aim: Submucosal tunneling endoscopic resection (STER) is an advanced endoscopic technique used for the minimally invasive removal of subepithelial lesions of the gastrointestinal (GI) tract. The aim of this study was to evaluate the safety and efficacy of STER for upper gastrointestinal subepithelial lesions.

Methods: A comprehensive search of major scholar databases (until December 15, 2023) was performed. Complete resection rate was considered the primary outcome. En bloc resection, operation duration, length of stay (LOS), local recurrence, and periprocedural complications were considered secondary outcomes. Random-effects (RE) and fixed-effects (FE) models were used to generate the outcome estimates.

Results: A total of 37 studies and 3795 patients were included. Pooled proportion of complete resection was 99% (95% CI 98.4-99.6%, p < 0.001). En bloc resection was achieved at 87.7% of cases. Overall mean operation duration was 64.2 min, while mean LOS was estimated at 4.93 days. The local recurrence rate was 0.1%. The two most common complications associated with STER were subcutaneous emphysema (5.5%) and pneumothorax (3%).

Conclusion: STER is a highly feasible and safe treatment modality for upper GI subepithelial lesions.

Keywords: Endoscopic; Gastrointestinal, subepithelial; Resection; Submucosal; Tunneling.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics Approval: Not applicable. Consent to Participate: Not applicable. Consent for Publication: Not applicable. Competing interests: The authors declare no competing interests.

Similar articles

References

    1. Li JH, Qin SM, Liu TW, Chen JQ, Li YT. The effect of endoscopic ultrasound on the precise selection of endoscopic treatment for submucosal tumors in the upper gastrointestinal tract. BMC Surg. 2023;23:1–11. - PubMed - PMC - DOI
    1. Xiu H, Zhao CY, Liu FG, Sun XG, Sun H, Liu XS. Comparing about three types of endoscopic therapy methods for upper gastrointestinal submucosal tumors originating from the muscularis propria layer. Scand J Gastroenterol. 2019;54:1481–6. - PubMed - DOI
    1. Tan Y, Lv L, Duan T, Zhou J, Peng D, Tang Y, et al. Comparison between submucosal tunneling endoscopic resection and video-assisted thoracoscopic surgery for large esophageal leiomyoma originating from the muscularis propria layer. Surg Endosc. 2016;30:3121–7. - PubMed - DOI
    1. Tun KM, Dhindsa BS, Dossaji Z, Deliwala SS, Narra G, Haque L, Lo C-H, Dhaliwal A, Chandan S, Ramai D, Singh S, Adler DG. Efficacy and safety of submucosal tunneling endoscopic resection for subepithelial tumors in the upper GI tract: a systematic review and meta-analysis of 2900 patients. iGIE. 2023;2(4):529–37.e2. https://doi.org/10.1016/j.igie.2023.08.005 .
    1. Aslanian HR, Sethi A, Bhutani MS, Goodman AJ, Krishnan K, Lichtenstein DR, et al. ASGE guideline for endoscopic full-thickness resection and submucosal tunnel endoscopic resection. VideoGIE. 2019;4:343–50. - PubMed - PMC - DOI

MeSH terms

LinkOut - more resources